Pharmaceutical Executive May 16, 2022
Pharmaceutical Executive Editorial Staff

The second of two parts of Pharmaceutical Executive’s Q&A discussion with Vinod Badami, Vice President, Data and Analytics at Indegene.

Pharmaceutical Executive: Does social listening provide real-world evidence (RWE) for drug development?

Vinod Badami: As mentioned earlier, HCPs are starting to get more comfortable with discussing medical-related information on social media. They evaluate the safety and efficacy of treatments through debates and discussions, promote new drug discoveries, and so on.

Similarly, patients have also taken to online review platforms or discussion forums to share their personal experiences, challenges, and side effects using specific treatments.

As a result, there is massive amount of information (albeit unstructured) that pharmaceutical organizations can leverage in addition to the structured RWE sources (like claims...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Interview / Q&A, Social Media, Technology, Trends
The Physician's Role in Curing the Social Media Epidemic
3 Ways Parents Protect Kids From Social Media’s Mental Health Effects
Social Media’s Assassination of Brian Thompson
California considers mental health warnings on social media: 3 things to know
Social Media Platforms Keep Kids Online Despite Mental Health Harms

Share This Article